Martina Centroni
Microtubule targeting agents: A bridge between Paclitaxel and Microtubules lateral contacts.
Rel. Jacek Adam Tuszynski. Politecnico di Torino, Master of science program in Biomedical Engineering, 2024
|
Preview |
PDF (Tesi_di_laurea)
- Thesis
Licence: Creative Commons Attribution Non-commercial No Derivatives. Download (2MB) | Preview |
|
|
Archive (ZIP) (Documenti_allegati)
- Other
Licence: Creative Commons Attribution Non-commercial No Derivatives. Download (195kB) |
Abstract
Microtubules (MT) are small cellular components that play a fundamental role in development, proliferation, spreading, and signaling of cells. The basic lattice of MTs is composed by the alternation of α and β protein subunits called tubulins. Over the decades, they have become the main target of drugs involved in the treatment against tumors. Chemotherapy drugs can be divided into two main categories: stabilizing and destabilizing agents, which, according to their properties, can stabilize or destabilize the lattice of MTs, leading to cell apoptosis. This is the case of Paclitaxel (PTX), a prominent chemotherapy drug used in breast cancer treatment. It aims to stabilize MTs through the firming of longitudinal and lateral contacts.
Even though PTX is one of the most powerful and useful drugs used nowadays, often there are cases of resistance towards this compound
Publication type
URI
![]() |
Modify record (reserved for operators) |
